Changes in IgG and total plasma protein glycomes in acute systemic inflammation

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Novokmet, Mislav ^a   Lukić, Edita ^b   Vučković, Frano ^a   Durić, Željko ^b   Keser, Toma ^c   Rajšl, Katarina ^c   Remondini, Daniel ^d   Castellani, Gastone ^d   Gašparović, Hrvoje ^b   Gornik, Olga ^c   Lauc, Gordan ^a,c  

^a GENOS GLYCOSCIENCE RESEARCH LABORATORY   (Croatia)

^b KBC Zagreb   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED IGG; IMMUNOGLOBULIN G; POLYSACCHARIDE;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLOOD; CARBOHYDRATE ANALYSIS; CHEMICAL PHENOMENA; CHEMISTRY; CLUSTER ANALYSIS; FEMALE; GLYCOBIOLOGY; GLYCOSYLATION; HEART SURGERY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOLOGY; INFLAMMATION; MALE; MIDDLE AGED; MOLECULAR GENETICS; MORTALITY; RISK FACTOR; SURVIVAL; VERY ELDERLY;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; CARBOHYDRATE SEQUENCE; CARDIAC SURGICAL PROCEDURES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLUSTER ANALYSIS; FEMALE; GLYCOMICS; GLYCOSYLATION; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; IMMUNOGLOBULIN G; INFLAMMATION; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYSACCHARIDES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84896320475     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04347     Document Type: Article

References (52)

1. Opdenakker, G., Rudd, P. M., Ponting, C. P. & Dwek, R. A. Concepts and principles of glycobiology. FASEB J 7, 1330-1337 (1993). (Pubitemid 23336160)
2. Moremen, K. W., Tiemeyer, M. & Nairn, A. V. Vertebrate protein glycosylation: diversity, synthesis and function. Nat Rev Mol Cell Biol 13, 448-462 (2012).
3. Skropeta, D. The effect of individual N-glycans on enzyme activity. Bioorg Med Chem 17, 2645-2653 (2009).
4. Alavi, A. & Axford, J. S. Sweet and sour: the impact of sugars on disease. Rheumatology (Oxford) 47, 760-770 (2008). (Pubitemid 351796358)
5. Gornik, O., Pavic, T. & Lauc, G. Alternative glycosylation modulates function of IgG and other proteins - Implications on evolution and disease. Biochim Biophys Acta 1820, 1318-1326 (2012).
6. Rudd, P. M., Elliott, T., Cresswell, P., Wilson, I. A. & Dwek, R. A. Glycosylation and the immune system. Science 291, 2370-2376. (2001). (Pubitemid 32231792)
7. Huhn, C., Selman, M. H., Ruhaak, L. R., Deelder, A. M. & Wuhrer, M. IgG glycosylation analysis. Proteomics 9, 882-913 (2009).
8. Jefferis, R. Glycosylation of recombinant antibody therapeutics. Biotechnol Prog 21, 11-16 (2005). (Pubitemid 40218466)
9. Karsten, C. M. et al. Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcgammaRIIB and dectin-1. Nat Med (2012).
10. Shields, R. L. et al. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J Biol Chem 277, 26733-26740 (2002). (Pubitemid 34951677)
11. Ferrara, C., Stuart, F., Sondermann, P., Brunker, P. & Umana, P. The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to nonfucosylated IgG glycoforms. J Biol Chem 281, 5032-5036 (2006). (Pubitemid 43847767)
12. Shinkawa, T. et al. The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem 278, 3466-3473 (2003). (Pubitemid 36801263)
13. Iida, S. et al. Nonfucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum immunoglobulin G on antibody-dependent cellular cytotoxicity through its high binding to FcgammaRIIIa. Clin Cancer Res 12, 2879-2887 (2006).
14. Kaneko, Y., Nimmerjahn, F. & Ravetch, J. V. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313, 670-673 (2006). (Pubitemid 44201145)
15. Anthony, R. M. & Ravetch, J. V. A novel role for the IgG Fc glycan: the antiinflammatory activity of sialylated IgG Fcs. J Clin Immunol 30 Suppl 1, , S9-14 (2010).
16. Anthony, R.M., Wermeling, F., Karlsson, M. C. & Ravetch, J. V. Identification of a receptor required for the anti-inflammatory activity of IVIG. Proc Natl Acad Sci USA 105, 19571-19578 (2008).
17. Anthony, R. M., Kobayashi, T., Wermeling, F. & Ravetch, J. V. Intravenous gammaglobulin suppresses inflammation through a novel T(H) 2 pathway. Nature 475, 110-113 (2011).
18. Anthony, R. M., Nimmerjahn, F., Ashline, D. J., Reinhold, V. N., Paulson, J. C. & Ravetch, J. V. Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science 320, 373-376 (2008). (Pubitemid 351555659)
19. Knez?ević, A. et al. Variability, Heritability and Environmental Determinants of Human Plasma N-Glycome. J Proteome Res 8, 694-701 (2009).
20. Pucic, M. et al. High throughput isolation and glycosylation analysis of IgGvariability and heritability of the IgG glycome in three isolated human populations. Mol Cell Proteomics 10, M111 010090 (2011).
21. Raja, S. G. & Dreyfus, G. D. Modulation of systemic inflammatory response after cardiac surgery. Asian cardiovascular & thoracic annals 13, 382-395 (2005). (Pubitemid 41824742)
22. Pintar, T. & Collard, C. D. The systemic inflammatory response to cardiopulmonary bypass. Anesthesiology clinics of North America 21, 453-464 (2003). (Pubitemid 37169539)
23. Moen, O. et al. Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg 63, 105-111 (1997). (Pubitemid 27039043)
24. de Mendonca-Filho, H. T. et al. Circulating inflammatory mediators and organ dysfunction after cardiovascular surgery with cardiopulmonary bypass: a prospective observational study. Crit Care 10, R46 (2006).
25. Sidebotham, D., McKee, A., Levy, J. & Gillham, M. Cardiothoracic Critical Care. Elsevier Health Sciences (2007).
26. Hu, D. Management of complex cardiovascular problems: the evidence-based medicine approach. Wiley-Blackwel (2007).
27. Lobato, E. B., Gravenstein, N. & Kirby, R. R. Complications in anesthesiology. Lippincott Williams & Wilkins (2007).
28. Bekesova, S. et al. N-glycans in liver-secreted and immunoglogulin- derived protein fractions. Journal of proteomics 75, 2216-2224 (2012).
29. Gornik, O., Wagner, J., Puc?ić, M., Knez?ević, A., Redzić, I. & Lauc, G. Stability of Nglycan profiles in human plasma. Glycobiology 19, 1547-1553 (2009).
30. Durand, E. et al. Performance analysis of EuroSCORE II compared to the original logistic EuroSCORE and STS scores for predicting 30-day mortality after transcatheter aortic valve replacement. The American journal of cardiology 111, 891-897 (2013).
31. Roques, F., Michel, P., Goldstone, A. R. & Nashef, S. A. The logistic EuroSCORE. European heart journal 24, 881-882 (2003).
32. Hart, G. W. & Copeland, R. J. Glycomics hits the big time. Cell 143, 672-676 (2010).
33. Lauc, G., Vojta, A. & Zoldos, V. Epigenetic regulation of glycosylation is the quantum mechanics of biology. Biochim Biophys Acta 1840, 65-70 (2013).
34. Lauc, G. & Zoldos?, V. Protein glycosylation - an evolutionary crossroad between genes and environment. Mol Biosyst 6, 2373-2379 (2010).
35. Zoldos, V., Horvat, T. & Lauc, G. Glycomics meets genomics, epigenomics and other high throughput omics for system biology studies. Curr Opin Chem Biol 17, 34-40 (2013).
36. Gornik, O. & Lauc, G. Glycosylation of serum proteins in inflammatory diseases. Dis Markers 25, 267-278 (2008).
37. Gornik, O. et al. Changes of serum glycans during sepsis and acute pancreatitis. Glycobiology 17, 1321-1332 (2007). (Pubitemid 350131309)
38. Gornik, O., Gornik, I., Gasparovic, V. & Lauc, G. Change in transferrin sialylation is a potential prognostic marker for severity of acute pancreatitis. Clin Biochem 41, 504-510 (2008).
39. Gornik, O., Gornik, I., Kolednjak, I. Z. & Lauc, G. Change of transferrin sialylation differs between mild sepsis and severe sepsis and septic shock. Intern Med 50, 861-869 (2011).
40. Piagnerelli, M. et al. Rapid alterations in transferrin sialylation during sepsis. Shock 24, 48-52 (2005). (Pubitemid 40946594)
41. Brinkman-van der Linden, E. C., de Haan, P. F., Havenaar, E. C. & van Dijk, W. Inflammation-induced expression of sialyl LewisX is not restricted to alpha1-acid glycoprotein but also occurs to a lesser extent on alpha1-antichymotrypsin and haptoglobin. Glycoconj J 15, 177-182 (1998). (Pubitemid 28260922)
42. van Dijk, W., Brinkman-Van der Linden, E. C. & Havenaar, E. C. Occurrence and possible function of inflammation-induced expression of sialyl Lewis-x on acutephase proteins. Adv Exp Med Biol 435, 145-150 (1998). (Pubitemid 128699279)
43. Sperandio, M. Selectins and glycosyltransferases in leukocyte rolling in vivo. FEBS J 273, 4377-4389 (2006). (Pubitemid 44401589)
44. Lowe, J. B. Glycosylation in the control of selectin counter-receptor structure and function. Immunol Rev 186, 19-36 (2002).
45. Mitoma, J. et al. Critical functions of N-glycans in L-selectin-mediated lymphocyte homing and recruitment. Nature Immunology 8, 409-418 (2007). (Pubitemid 46745416)
46. Miyoshi, E., Moriwaki, K. & Nakagawa, T. Biological function of fucosylation in cancer biology. J Biochem 143, 725-729 (2008). (Pubitemid 351918934)
47. Kris?tić, J. et al. Glycans are a novel biomarker of chronological and biological age. The journals of gerontology Series A, Biological sciences and medical sciences (2013).
48. Menni, C. et al. Glycosylation of Immunoglobulin G: Role of genetic and epigenetic influences. PLoS One 8, e82558 (2013).
49. Wandall, H. H. et al. The origin and function of platelet glycosyltransferases. Blood (2012).
50. Jones, M. B., Nasirikenari, M., Lugade, A. A., Thanavala, Y. & Lau, J. T. Antiinflammatory IgG production requires functional P1 promoter in betagalactoside alpha2, 6-sialyltransferase 1 (ST6Gal-1) gene. J Biol Chem 287, 15365-15370 (2012).
51. Nimmerjahn, F. & Ravetch, J. V. Anti-inflammatory actions of intravenous immunoglobulin. Annu Rev Immunol 26, 513-533 (2008). (Pubitemid 351600384)
52. Knezevic, A., Bones, J., Kracun, S. K., Gornik, O., Rudd, P. M. & Lauc, G. High throughput plasma N-glycome profiling using multiplexed labelling and UPLC with fluorescence detection. The Analyst 136, 4670-4673 (2011).